156 related articles for article (PubMed ID: 600713)
1. [Hyperammonemia and hepatic encephalopathy in cirrhotics receiving spironolactone (author's transl)].
Imler M; Schlienger JL
Nouv Presse Med; 1977 Nov; 6(37):3407-10. PubMed ID: 600713
[TBL] [Abstract][Full Text] [Related]
2. Why and when to measure ammonemia in cirrhosis?
Mallet M; Weiss N; Thabut D; Rudler M
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):505-511. PubMed ID: 29551609
[TBL] [Abstract][Full Text] [Related]
3. The complications of diuretic therapy in patients with cirrhosis.
Sherlock S; Walker JG; Senewiratne B; Scott A
Ann N Y Acad Sci; 1966 Nov; 139(2):497-505. PubMed ID: 5230290
[No Abstract] [Full Text] [Related]
4. Ammonia metabolism in the gut.
Summerskill WH; Wolpert E
Am J Clin Nutr; 1970 May; 23(5):633-9. PubMed ID: 5444997
[No Abstract] [Full Text] [Related]
5. [Present-day therapy of hepatic encephalopathy (author's transl)].
Imler M
MMW Munch Med Wochenschr; 1976 Dec; 118(52-53):1685-94. PubMed ID: 827698
[TBL] [Abstract][Full Text] [Related]
6. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
Wang LJ; Cai JT; Chen T; Lü B; Si JM
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
[TBL] [Abstract][Full Text] [Related]
7. Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats.
Yamamoto H; Sugihara N
Toxicol Appl Pharmacol; 1987 Dec; 91(3):461-8. PubMed ID: 2962338
[TBL] [Abstract][Full Text] [Related]
8. Medium chain triglycerides and hepatic encephalopathy.
Morgan MH; Bolton CH; Morris JS; Read AE
Gut; 1974 Mar; 15(3):180-4. PubMed ID: 4841275
[TBL] [Abstract][Full Text] [Related]
9. Methionine-induced hepatic coma in dogs.
Merino GE; Jetzer T; Doizaki WM; Najarian JS
Am J Surg; 1975 Jul; 130(1):41-46. PubMed ID: 1155716
[TBL] [Abstract][Full Text] [Related]
10. [Urea and spironolactone therapy].
Schwarzbach W; Bunzl W
Munch Med Wochenschr; 1973 Jan; 115(3):76-80. PubMed ID: 4739290
[No Abstract] [Full Text] [Related]
11. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
[TBL] [Abstract][Full Text] [Related]
12. Gut ammonia production and its modulation.
Romero-Gómez M; Jover M; Galán JJ; Ruiz A
Metab Brain Dis; 2009 Mar; 24(1):147-57. PubMed ID: 19067141
[TBL] [Abstract][Full Text] [Related]
13. Complications of diuretic therapy in hepatic cirrhosis.
Sherlock S; Senewiratne B; Scott A; Walker JG
Lancet; 1966 May; 1(7446):1049-52. PubMed ID: 4160838
[No Abstract] [Full Text] [Related]
14. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
Pirotte J; Guffens JM; Devos J
Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
[No Abstract] [Full Text] [Related]
15. Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol.
Snady H; Lieber CS
Am J Gastroenterol; 1988 Mar; 83(3):249-55. PubMed ID: 3344727
[TBL] [Abstract][Full Text] [Related]
16. The effect of chronic uremia on portal and systemic ammonemia in normal and portal-strictured rats.
Imler M; Schlienger JL
J Lab Clin Med; 1979 Dec; 94(6):872-8. PubMed ID: 501211
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
18. Role of ammonia and inflammation in minimal hepatic encephalopathy.
Shawcross DL; Wright G; Olde Damink SW; Jalan R
Metab Brain Dis; 2007 Mar; 22(1):125-38. PubMed ID: 17260161
[TBL] [Abstract][Full Text] [Related]
19. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy.
Nicolao F; Efrati C; Masini A; Merli M; Attili AF; Riggio O
J Hepatol; 2003 Apr; 38(4):441-6. PubMed ID: 12663235
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
